Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.61
- +0.02+0.56%
Market Closed Dec 20 15:00 CST
2.57BMarket Cap-156.96P/E (TTM)
3.62High3.57Low319.15KlotVolume3.58Open3.59Pre Close114.65MTurnover4.48%Turnover RatioLossP/E (Static)712.84MShares4.3852wk High4.55P/B2.57BFloat Cap2.2152wk Low3.95Limit Up712.84MShs Float22.10Historical High3.23Limit Down1.39%Amplitude2.21Historical Low--Dividend TTM3.59Avg Price171.49KlotAsk--Div YieldTTM100Lot Size147.38KlotBid
Zhejiang Yatai Pharmaceutical News
Zhejiang Yatai Pharmaceutical: Announcement about changes in shareholding structure of the controlling shareholder.
Zhejiang Yatai Pharmaceutical: Announcement on the completion of shareholding plan by the controlling shareholder and expiration of the implementation period.
Zhejiang Yatai Pharmaceutical: Announcement on the progress of plans to increase the controlling shareholders' holdings
Asia Pacific Pharmaceutical: Announcement on the progress of the company\'s controlling shareholder increasing the company\'s shares by more than 1%
Asia Pacific Pharmaceutical: Announcement on the Company\'s Controlling Shareholder\'s Increase in the Company\'s Shares and Plans to Increase Its Shareholdings
Asia Pacific Pharmaceutical: Announcement on not revising the debt-to-equity conversion price of AsiaPharma Pharmaceuticals
Asia Pacific Pharmaceutical: Announcement on not revising the debt-to-equity conversion price of AsiaPharma Pharmaceuticals
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2022
Asia Pacific Pharmaceuticals: Announcement on downward revision of convertible corporate bond conversion prices
Asia Pacific Pharmaceuticals: Announcement on the Board's proposal to revise the convertible price of convertible corporate bonds to shares downward
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the second quarter of 2022
Asia Pacific Pharmaceuticals: Detailed Report on Changes in Equity
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2022
Asia Pacific Pharmaceutical: Announcement on Shareholders' Agreement to Transfer the Company's Shares and the Completion of the Transfer
Asia Pacific Pharmaceutical: Prompt Announcement on Shareholders' Agreement to Transfer Company Shares and Changes in Equity
Asia Pacific Pharmaceuticals: Detailed Report on Changes in Equity
Asia Pacific Pharmaceuticals: Simplified Statement of Changes in Equity
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2021
Asia Pacific Pharmaceutical: Announcement on the transfer of some of the shares of the original controlling shareholder and their co-actors through judicial auction
